Aimmune Therapeutics, Inc. Debt to Equity Ratio 2015-2020 | AIMT
Current and historical debt to equity ratio values for Aimmune Therapeutics, Inc. (AIMT) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Aimmune Therapeutics, Inc. debt/equity for the three months ending June 30, 2020 was .
Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2020-06-30 |
$0.19B |
$0.18B |
1.03 |
2020-03-31 |
$0.19B |
$0.24B |
0.79 |
2019-12-31 |
$0.10B |
$0.10B |
0.97 |
2019-09-30 |
$0.10B |
$0.15B |
0.63 |
2019-06-30 |
$0.09B |
$0.21B |
0.46 |
2019-03-31 |
$0.09B |
$0.26B |
0.34 |
2018-12-31 |
$0.04B |
$0.30B |
0.14 |
2018-09-30 |
$0.04B |
$0.25B |
0.16 |
2018-06-30 |
$0.04B |
$0.29B |
0.14 |
2018-03-31 |
$0.03B |
$0.33B |
0.10 |
2017-12-31 |
$0.03B |
$0.18B |
0.16 |
2017-09-30 |
$0.02B |
$0.21B |
0.11 |
2017-06-30 |
$0.02B |
$0.24B |
0.08 |
2017-03-31 |
$0.01B |
$0.27B |
0.04 |
2016-12-31 |
$0.01B |
$0.29B |
0.05 |
2016-09-30 |
$0.01B |
$0.16B |
0.08 |
2016-06-30 |
$0.01B |
$0.18B |
0.04 |
2016-03-31 |
$0.01B |
$0.19B |
0.03 |
2015-12-31 |
$0.01B |
$0.21B |
0.03 |
2015-09-30 |
$0.00B |
$0.22B |
0.02 |
2015-06-30 |
$0.00B |
$0.06B |
0.07 |
2015-03-31 |
$0.00B |
|
0.00 |
2014-09-30 |
$0.00B |
|
0.00 |
2014-06-30 |
$0.00B |
|
0.00 |